Organogenesis Holdings (ORGO) Current Assets (2016 - 2025)
Organogenesis Holdings has reported Current Assets over the past 10 years, most recently at $362.2 million for Q4 2025.
- Quarterly results put Current Assets at $362.2 million for Q4 2025, up 26.67% from a year ago — trailing twelve months through Dec 2025 was $362.2 million (up 26.67% YoY), and the annual figure for FY2025 was $362.2 million, up 26.67%.
- Current Assets for Q4 2025 was $362.2 million at Organogenesis Holdings, up from $299.7 million in the prior quarter.
- Over the last five years, Current Assets for ORGO hit a ceiling of $362.2 million in Q4 2025 and a floor of $185.2 million in Q1 2021.
- Median Current Assets over the past 5 years was $227.1 million (2021), compared with a mean of $239.4 million.
- Biggest five-year swings in Current Assets: soared 71.41% in 2021 and later dropped 6.52% in 2023.
- Organogenesis Holdings' Current Assets stood at $227.0 million in 2021, then dropped by 1.93% to $222.6 million in 2022, then grew by 1.09% to $225.0 million in 2023, then rose by 27.06% to $285.9 million in 2024, then increased by 26.67% to $362.2 million in 2025.
- The last three reported values for Current Assets were $362.2 million (Q4 2025), $299.7 million (Q3 2025), and $260.2 million (Q2 2025) per Business Quant data.